-
FIFA boss Infantino faces questions on eve of World Cup
-
Iran attacks US bases in Jordan and Bahrain
-
Tech leads Asia losses as rollercoaster week rumbles on
-
Belfast stabbing suspect due in court after night of violence
-
Saudi's new national carrier gets off ground despite war, delays
-
Eddie Jones eyes Mourinho-like laundry stunt to escape ban
-
Bollywood's Imtiaz Ali bets on Gen Z thirst for love
-
Messi plushies see roaring trade as China firms get World Cup boost
-
Messi sparkles on return as Somali referee says World Cup dream over
-
Iran, US trade blows as Middle East peace deal draws no nearer
-
Salt: integral ingredient of sumo stars' art
-
Staal shines as Carolina beat Vegas 5-3 to level Stanley Cup Final
-
Messi scores on injury return as Argentina beat Iceland in World Cup warm-up
-
Art, maths and killing: Ukraine drone chief's formula to stop Russia
-
Tech leads Asia losses, oil rises as rollercoaster week rumbles on
-
Messi set to return as Somali referee says World Cup dream over
-
Former Wallabies skipper Wright signs for Welsh club Ospreys
-
Pope to bless Barcelona's Sagrada Familia, world's tallest church
-
Emotional World Cup return to Mexico for South Africa coach Broos
-
Bill Gates faces questioning in US Congress over Epstein ties
-
'The Donald of Dubai': property tycoon seeks to become data king
-
PGA Tour to co-sanction Australian Open in global push
-
Elon Musk, after DOGE and politics, bets on SpaceX IPO
-
Saudis in World Cup spotlight after $2bn spending spree
-
Mexico doubles down on security before 2026 World Cup
-
US must not be 'too honest' at World Cup, says Roldan
-
Italian astronaut to pilot Artemis III mission
-
North Korea says Xi's visit produced 'far-reaching blueprint' for ties
-
Benfica say farewell to Mourinho as Real Madrid return nears
-
Protesters torch buildings and vehicles, block roads over Belfast stabbing
-
US strikes Iran after Apache helicopter downing
-
Threats to US lawmakers spiked after Meta eased moderation: watchdog
-
Nick Reiner seeks trust fund money for parent murder defense
-
Spain, France qualify for 2027 Women's World Cup as England wait
-
Protesters torch building and vehicles, block roads over Belfast stabbing
-
A woman in charge of the UN? Candidates feel it's about time
-
US tech shares resume sell-off while oil prices retreat
-
Protesters block road to Mexican World Cup stadium
-
White House World Cup chief defends visa ban for Somali referee, Iranians
-
Serena back in the groove on triumphant return to tennis
-
'It doesn't matter': US star Reyna looks past World Cup scandal
-
Somali referee says World Cup 'dream' ruined
-
Knicks ready to 'throw the first punch' in NBA Finals
-
'Beaten to death': the grim toll of Ecuador's security crackdown
-
Anthropic opens most powerful AI model to public with safeguards
-
Serena Williams makes winning return in Queen's Club doubles
-
Trump vows response after Iran shoots down US helicopter
-
Real Madrid's 150 mn euros bid for Atletico's Alvarez rejected
-
Spurs handling physicality of Knicks and New York hostility
-
Peru election chief tells AFP count could take two weeks
What is microRNA? Nobel-winning discovery explained
The Nobel Prize in Medicine was awarded on Monday to two US scientists for discovering microRNA, a previously unknown type of genetic switch which is hoped can pave the way for new medical breakthroughs.
But while several treatments and tests are under development using microRNAs against cancer, heart disease, viruses and other illnesses, none have actually yet reached patients.
And the world paid little attention when the new Nobel laureates Victor Ambros and Gary Ruvkun revealed their discovery decades ago, thinking it was just "something weird about worms", Cambridge University geneticist Eric Miska told AFP.
Here is an explainer about how exactly these tiny genetic switches work inside our bodies.
- What is microRNA? -
Each cell in the human body has the same set of instructions, called DNA. Some turn into brain cells, while others become muscles.
So how do the cells know what to become? The relevant part of the DNA's instructions is pointed to via a process called gene regulation.
Ribonucleic acid (RNA) normally serves as a messenger. It delivers the instructions from the DNA to proteins, which are the building blocks of life that turn cells into brains -- or muscles.
Miska gave the example of the messenger RNA vaccines rolled out against Covid-19 during the pandemic, which insert a message with new instructions to build proteins that block viruses.
But the two new Nobel winners Ambros and Ruvkun discovered a whole new type of gene regulator that had previously been overlooked by science.
Rather than being the messenger which relays information, microRNA instead acts as a switch to turn other genes off and on.
"This was a whole new level of control that we had totally missed," said Miska, who has worked on microRNA for two decades, including with the new Nobel laureates.
"The discovery of microRNAs brought an additional level of complexity by revealing that regions that were thought to be non-coding play a role in gene regulation," French researcher Benoit Ballester told AFP.
- What did the Nobel winners do? -
Back in the 1980s, Ambros and Ruvkun had been working separately on how genes interact in one-millimetre-long roundworms called C.elegans.
When they compared their work, it led to the discovery of microRNA. Ambros revealed the finding in a 1993 paper.
"Nobody really paid much attention," Miska said, explaining that most scientists at the time thought it only applied to worms.
Then in 2000, Ruvkun published research showing that microRNA is present right across the animal kingdom, including in humans and even some viruses.
"This was not just something weird that worms do, but in fact all animals and plants are totally dependent for development and normal function on them," Miska said.
More than a thousand genes that respond to microRNAs are now believed to be in the human body.
- How could this help us? -
There are numerous new treatments and tests using microRNA that are undergoing trials but none have been made widely available.
"Though there are no very clear applications available yet in microRNAs, understanding them, knowing that they exist, understanding their counter-regulatory networks, is always the first step," the Karolinska Institute's Gunilla Karlsson Hedestam told journalists in Stockholm.
MicroRNAs are particularly promising for fighting cancer because some of these switches "act as a tumour suppressor, so they put a brake on cells dividing inappropriately," Miska said.
Others, meanwhile, induce "cells to divide, which can lead to cancer", he added.
Because many viruses use microRNAs, several antiviral drugs are at varying stages of development, including for hepatitis C.
One complicating factor has been that microRNAs can be unstable.
But scientists also hope they can be used as a test called a "biomarker", which could reveal what type of cancer a patient could be suffering from, for example.
- What next? -
It also appears probable that microRNAs could be involved in the evolution of our species, Miska said.
While human brains are difficult to study, Miska hoped future research will discover more.
G.AbuOdeh--SF-PST